-
1
المؤلفون: Pascale Exer, Giorgio Tamborrini, Pascal Zufferey, Burkhard Möller, Adrian Ciurea, Monika Hebeisen, Michael John Nissen, Raphael Micheroli, Almut Scherer
المساهمون: University of Zurich, Ciurea, Adrian
المصدر: PLoS ONE
PloS one, vol. 14, no. 5, pp. e0216746
PLoS ONE, Vol 14, Iss 5, p e0216746 (2019)
Hebeisen, Monika; Scherer, Almut; Micheroli, Raphael; Nissen, Michael J; Tamborrini, Giorgio; Möller, Burkhard; Zufferey, Pascal; Exer, Pascale; Ciurea, Adrian (2019). Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis. PLoS ONE, 14(5), e0216746. Public Library of Science 10.1371/journal.pone.0216746 <http://dx.doi.org/10.1371/journal.pone.0216746>
PLOS ONE, Vol. 14, No 5 (2019) P. e0216746مصطلحات موضوعية: Male, Time Factors, Physiology, medicine.medical_treatment, Ankylosing Spondylitis, Cancer Treatment, Biochemistry, Etanercept, White Blood Cells, Animal Cells, Immune Physiology, Medicine and Health Sciences, 610 Medicine & health, ddc:616, Innate Immune System, Multidisciplinary, Pharmaceutics, Hazard ratio, Anti-Inflammatory Agents, Non-Steroidal, 10051 Rheumatology Clinic and Institute of Physical Medicine, Antibodies, Monoclonal, Middle Aged, C-Reactive Proteins, TNF inhibitor, Oncology, Antirheumatic Agents, Medicine, Cytokines, Female, Cellular Types, medicine.drug, Research Article, Adult, musculoskeletal diseases, medicine.medical_specialty, Drug Synthesis, Science, Immune Cells, Immunology, 1100 General Agricultural and Biological Sciences, Gastroenterology and Hepatology, Autoimmune Diseases, Drug Therapy, 1300 General Biochemistry, Genetics and Molecular Biology, Internal medicine, Adalimumab/administration & dosage, Anti-Inflammatory Agents, Non-Steroidal/administration & dosage, Antibodies, Monoclonal/administration & dosage, Antirheumatic Agents/administration & dosage, Etanercept/administration & dosage, Humans, Infliximab/administration & dosage, Spondylarthritis/drug therapy, Tumor Necrosis Factor Inhibitors/administration & dosage, Spondylarthritis, Adalimumab, medicine, Ankylosing spondylitis, 1000 Multidisciplinary, Blood Cells, Proportional hazards model, business.industry, Pharmaceutical Processing Technology, Inflammatory Bowel Disease, Biology and Life Sciences, Proteins, Cell Biology, Molecular Development, medicine.disease, Golimumab, Infliximab, Immune System, 570 Life sciences, biology, Clinical Immunology, Tumor Necrosis Factor Inhibitors, Clinical Medicine, business, Developmental Biology
وصف الملف: pone.0216746.pdf - application/pdf; application/pdf
-
2
المؤلفون: Nataliya Yeremenko, Inka A. Fluri, Talia E. Latuhihin, Henriëtte M. de Jong, Leonieke J J van Mens, S. Menegatti, Marleen G H van de Sande, Lars Rogge, Sijia Chen, Iris C Blijdorp, Dominique Baeten, Arno W R van Kuijk
المساهمون: Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University of Amsterdam [Amsterdam] (UvA), Institut Pasteur [Paris], Department of Rheumatology & Clinical Immunology [Amsterdam, the Netherlands] (Amsterdam UMC), Amsterdam Infection & Immunity Institute [Amsterdam, the Netherlands]-University of Amsterdam [Amsterdam] (UvA), Institut Pasteur [Paris] (IP), University of Amsterdam [Amsterdam] (UvA)-Amsterdam Infection & Immunity Institute [Amsterdam, the Netherlands], Clinical Immunology and Rheumatology, Graduate School, AII - Inflammatory diseases, 01 Internal and external specialisms, General Internal Medicine, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism
المصدر: Arthritis & rheumatology
Arthritis & rheumatology, Wiley, 2018, 70 (12), pp.1994-2002. ⟨10.1002/art.40581⟩
Arthritis & rheumatology, 2018, 70 (12), pp.1994-2002. ⟨10.1002/art.40581⟩
Arthritis & rheumatology (Hoboken, N.J.), 70(12), 1994-2002. John Wiley and Sons Ltdمصطلحات موضوعية: 0301 basic medicine, Male, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Synovial Membrane / drug effects, Severity of Illness Index, Spondylarthritis / immunology, 0302 clinical medicine, Immunopathology, Monoclonal, Immunology and Allergy, Synovial Membrane / immunology, Humanized, medicine.diagnostic_test, Spondylarthritis / drug therapy, Interleukin-17, Synovial Membrane, Antibodies, Monoclonal, Antirheumatic Agents / pharmacology, Middle Aged, 3. Good health, Cytokine, Treatment Outcome, Antirheumatic Agents, Erythrocyte sedimentation rate, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, Interleukin 17, Interleukin-17 / immunology, Adult, Monoclonal / pharmacology, Immunology, Antibodies, Monoclonal, Humanized, Antibodies, 03 medical and health sciences, Psoriatic arthritis, Immune system, Rheumatology, Spondylarthritis, medicine, Biomarkers / blood, Humans, Spondylarthritis / blood, 030203 arthritis & rheumatology, Ankylosing spondylitis, business.industry, medicine.disease, 030104 developmental biology, Secukinumab, business, Biomarkers
إعادة تعيين المنقحات
عرض المنقحات (%%عد%%)